Laprixa ®

Via the previous OP-Zuid project, 01945, Corporis Medical was able to develop the Laprixa System in collaboration with its partners. Medanco B.V. from Veldhoven supported the development of the probe that performs the measurement on the bowel tissue, by injection molding the components and assembling the probe in their cleanroom. AIM B.V. from Brunssum contributed to the development of the module that processes and presents the measurement data. The Laprixa technology has been tested in pre-clinical in vivo models, which showed promising results.

 

Although the current Laprixa System is already quite impressive, Corporis Medical is constantly searching for ways to go the extra mile. Together with our partners Medanco B.V. and AIM B.V., and with the support of Stimulus via OP-Zuid project STIM-0053, we are now advancing the development of the Laprixa System even further, by integrating oxygen saturation measurements. Considering that oxygen saturation is one of the most important indicators of anastomosis wound healing capacity, this improvement offers the surgeon even more support in finding an adequate anastomosis location. This improvement demands an update to both the Laprixa Probe and Module. Furthermore, we will set up the production chain of the Laprixa System, which involves installing a cleanroom at AIM B.V. Finally, verification and validation tests will be performed to ensure the Laprixa System meets all requirements. We aim to close this project with a market-ready product, that has been tested in both pre-clinical and clinical environments, with positive results.

 

We’re excited to collaborate with our partners to make this project a success to improve patient care!